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Abstract

Cancer screening tests are important tools to combat cancer-related morbidity and mortality. There is limited up-to-date research on
spatial and temporal variations of colorectal and breast cancer screening in the United States.
County-level data of cancer screening adherence rates were generated from 2008 to 2012 Behavioral Risk Factor Surveillance
System. We performed the univariate local indicators for spatial analyses (LISA) for the geographic differences of screening
adherence rate and the differential LISA for the change of screening adherence rate from 2008 to 2012.
In the univariate LISA, low-to-low clusters were consistently identiﬁed in counties of New Mexico, Wyoming, and Mississippi (P < 0.05)
for both screenings. In the differential LISA, we found low-to-low clusters in Indiana counties (P < 0.05) for mammography screening,
which implied that counties with a below-average difference in mammography adherence were surrounded by counties of belowaverage difference in adherence rates. A high-to-high cluster was also identiﬁed in the southern Appalachian counties for mammography
screening (P < 0.05). No obvious spatial pattern was found for the colorectal cancer screening adherence rate across the United States.
We found low-to-low clusters over time in adherence to screening guidelines for both cancer types in New Mexico, Wyoming, and
Mississippi, and clusters of potential decrease in adherence to mammography screening guideline in counties of Indiana. The study
also showed improvement on mammography screening clustered in southern Appalachia. The methodology adopted in this study
identiﬁed areas with clusters of consistent low adherence to screening and a decrease in adherence, which implies that further
research and intervention is warranted.
Abbreviations: ACG = American College of Gastroenterology, ACS = American Cancer Society, BRFSS = Behavioral Risk Factor
Surveillance System, CRC = colorectal cancer, FIPS = Federal Information Processing Standards, FOBT = fecal occult blood test,
LISA = local indicators for spatial analyses, SD = standard deviation, USPSTF = United States Preventive Services Task Force.
Keywords: spatial-temporal variations, breast cancer, colorectal cancer, cancer screening, mammography

cancer is the highest among all types of cancer, with breast cancer
at around $16 billion, followed by CRC at $14 billion in 2010.[3]
Cancer screening tests are important tools to combat cancerrelated morbidity and mortality. Mammography has been shown
to be associated with signiﬁcant reduction in late breast cancer
diagnosis and increases in overall survival.[4,5] According to the
American Cancer Society (ACS), women without breast
symptoms aged 45 to 54 years are recommended to receive
mammography screening every year, and those who are aged
55 years and older should have mammography screening every
2 years.[6] The United States Preventive Services Task Force
(USPSTF) recommends biannual screening for females aged
between 50 and 74 years (see Table 1, Supplemental Content,
which illustrates the recommendations for breast cancer
screening, http://links.lww.com/MD/B472). According to National Cancer Institute (NCI), the overall rate of breast cancer
screening among average-risk women aged 50 to 74 years was
72.6% in 2013.[7] Additionally, mammogram screening was
associated with reduced risk of breast cancer death among
women aged 74 years and older with mild or moderate level of
comorbidity as compared with those with severe comorbidity.
The factors associated with adherence to mammography
screening included age, income, health insurance coverage,
available medical resource, family history of breast cancer, and
breast problems in the past.[8,9]
Colorectal cancer screenings include, but are not limited to,
colonoscopy, sigmoidoscopy, guaiac-based fecal occult blood test

1. Introduction
Breast cancer and colorectal cancer (CRC) are 2 common types of
cancers. In 2016, the estimated new cases for breast cancer
and colon cancer among Americans were over 379,000.[1] In
addition, 40,450 estimated deaths for breast cancer (among
females) and 49,190 for CRC might be expected in 2016.[2]
Moreover, the medical cost associated with these 2 types of

Editor: Dimitrios Paraskevis.
There is no conﬂict of interest.
Supplemental Digital Content is available for this article.
a
Department of Pharmaceutical Systems and Policy, West Virginia University,
School of Pharmacy, Morgantown, WV, b University of Texas at El Paso, School
of Pharmacy, El Paso, TX.
∗

Correspondence: Jongwha Chang, Universtiy of Texas, School of Pharmacy, El
Paso, TX (e-mail: jchang@utep.edu).

Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc.
This is an open access article distributed under the terms of the Creative
Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NCND), where it is permissible to download and share the work provided it is
properly cited. The work cannot be changed in any way or used commercially
without permission from the journal.
Medicine (2016) 95:51(e5656)
Received: 1 September 2016 / Received in ﬁnal form: 14 November 2016 /
Accepted: 21 November 2016
http://dx.doi.org/10.1097/MD.0000000000005656

1

Feng et al. Medicine (2016) 95:51

Medicine

health-related risk behaviors, chronic health conditions, and use
of preventive services from noninstitutionalized US adults every
year.[20] The BRFSS questionnaires are composed of core
questions, optional modules, and state-speciﬁc questions. Cancer
screening questions were core questions that were asked every
even year.

(FOBT), fecal immunochemical test, and multitargeted stool
DNA test (see Table 1, Supplemental Content, which illustrates
the recommendations for CRC screening, http://links.lww.com/
MD/B472). Colonoscopy is widely recommended and offered as
a primary screening for CRC. It is more commonly used among
individuals in the United States.[10,11] Screenings with sigmoidoscopy and FOBT have also consistently demonstrated prevention of deaths from CRC.[11,12] Screenings by FOBT every year,
ﬂexible sigmoidoscopy every 5 years, or colonoscopy every 10
years are recommended by the USPSTF and the ACS, and also the
American College of Gastroenterology (ACG). The USPSTF
recommends CRC screening for individuals aged between 50 and
75 years.[13] Relative to breast cancer screening, the CRC
screening rate in the United States was much lower at 58%
reported by a 2013 study.[7,14]
A decreasing trend in self-reported use of mammography was
observed from 1999 to 2005 in the United States,[15,16] whereas
an ascending trend was observed for the screening rate of CRC in
the United States from 2000 to 2003.[17] In addition, geographic
disparities on CRC screenings were reported by Lian et al[18] in
Missouri. They found considerable geographic variations of CRC
screening in Missouri on the 5-digit zip code level. However,
there is a lack of updated report on spatial-temporal variations of
adherence to screening guidelines for breast cancer and CRC
across the United States. Understanding these variations can help
evaluate relevant interventions, initiatives, or policies in different
regions, and identify target areas and population for the further
development of strategies and policies to advance the adherence
to guideline recommendations. This may signiﬁcantly improve
population health and alleviate health disparities arising from the
geographic location.
With the advancement of geo-techniques in epidemiology and
availability of software tools, it would also be beneﬁcial to
explore and illustrate these spatial-temporal variations by
applying advanced spatial analysis tools to better inﬂuence
healthcare planning. The local indicators for spatial analyses
(LISA)[19] can be used to help identify the spatial patterns, such as
low-to-low clusters, high-to-high clusters, low-to-high outliers,
and high-to-low outliers. It includes the univariate LISA for
exploring geographic variations such as the areas with clusters of
low adherence to screening guidelines; and the differential LISA
for incorporating the temporal changes such as identifying the
areas with clusters of potential decreases and increases in
adherence. Therefore, the study objective was to explore the
spatial and temporal variations of adherence to breast and CRC
screening guidelines, and narrow the focus of these variations on
the county level in the United States from 2008 to 2012.

2.3. Study population
We utilized the most recent screening guideline (until May 2016)
for breast cancer from the ACS[6] and for CRC from the
USPSTF.[13] The eligible populations were: females between the
age 46 and 55 years having mammography screening no less than
once within the last year; and females aged 56 and over getting
mammography screening no less than once within the past 2 years;
individuals between the age 51 and 75 years who had at least 1
colonoscopy in the past 10 years, 1 sigmoidoscopy in the past 5
years, or 1 FOBT in the past year for CRC screening; who had no
missing data on mammography screening, or sigmoidoscopy,
colonoscopy, and FOBT, and also no missing data on the Federal
Information Processing Standards (FIPS) codes of the county;
and completed the interview in 2008 and 2012, respectively
(unweighted N = 165,118 for CRC in 2008; N = 195,164 for CRC
in 2012; unweighted N = 147,487 for breast cancer in 2008; N =
160,820 for breast cancer in 2012). Individual data were weighted
and adjusted for the unequal probability of selection, differential
nonresponse, and possible deﬁciencies in the sampling frame.
Adherence rates to screening guidelines for both cancers were
aggregated at the county level. Counties with relative standard
error (RSE) over 30% were excluded from analyses, according to
the suggestions from the data provider.[20]
2.4. Measurement
The main variables of this study were county-level adherence rates
to the mammography guideline and the CRC screening (sigmoidoscopy/colonoscopy/FOBT) guideline. We ﬁrst obtained individual-level data, which included mammography screening guideline
adherence (yes/no), and CRC screening guideline adherence
(yes/no). The guideline adherence was based on the questions
asked in BRFSS, including “Have you ever had a mammography
screening?” and “How long has it been since you had your last
mammography screening?”; and “Have you ever had either of
these exams (sigmoidoscopy or colonoscopy) or FOBT?,” “Was
your MOST RECENT exam a sigmoidoscopy/colonoscopy?,” and
“How long has it been since you had your last sigmoidoscopy/
colonoscopy/FOBT?” Second, we derived the weighted percent of
individuals who adhered to the guideline in 2008 and 2012,
respectively, and obtained the county-level adherence rate to the
guideline for mammography and CRC screening.

2. Methods
2.1. Study design
We conducted an ecological study using aggregated data to study
the spatial-temporal variations of adherence to mammography
and CRC (sigmoidoscopy/colonoscopy/FOBT) screening guideline at the county level across the United States. Ethical approval
was waived since we used public available de-identiﬁed data.

2.5. Geo-mapping
Geo-mapping using ArcGIS 10.3 (ESRI, Redlands, CA) was applied
to visualize the rates of mammography and CRC screening for
counties in the United States. We used 60%, 70%, 80%, and 90%
as cut-off points for the classiﬁcation scheme in the choropleth maps
for mammography screening, and 50%, 60%, 70%, and 80% for
CRC screening. The cut-off points were chosen based on the data
distributions and the facilitation of a better comparison between
2008 and 2012. Lighter color represented lower rates, whereas
deeper color represented higher rates. Counties with missing values
or excluded were ﬁlled with white color.

2.2. Data source
Data were derived from the Behavioral Risk Factor Surveillance
System (BRFSS) 2008 and 2012.[20] The BRFSS collects data
from all 50 states and the District of Columbia through
standardized and random-digit dialed telephone survey on the
2
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Figure 1. County-level adherence to mammography screening guideline in 2008 and 2012. The choropleth maps illustrate the county-level adherence to mammography
screening guideline in 2008 and 2012, using cut-off points at 60%, 70%, 80%, and 90%.Counties with missing values or excluded are ﬁlled with white color.

above-average difference (mean for CRC screening = 3.08; mean
for mammography = 1.95) was also surrounded with counties
of above-average difference.
We utilized the Queen Contiguity weights matrix that deﬁned
those counties sharing a border or vertex/corner as a county’s
neighbors. The LISA statistic was calculated for each observation
and cluster, with the signiﬁcant level at P < 0.05. In addition,
global Moran I and differential Moran I statistics were employed
to assess spatial autocorrelation. Moran I varies from 1 to 1.
“+1” indicates a strong positive spatial correlation (ie, spatial
clustering), and “ 1” indicates a strong negative spatial
correlation that implies spatial dispersion, and a 0 value means
a random spatial pattern.[16] A signiﬁcant level at P < 0.05 was
used to assess spatial autocorrelation.
Sensitivity analyses using ACS guideline for colorectal cancer
and USPSTF recommendation for mammography screening were
conducted.

2.6. Spatial analyses
We exported the shape ﬁles from ArcGIS to GeoDa 1.8
software[19] to conduct LISA to study the spatial-temporal
variations on adherence. First, we conducted the univariate LISA
to identify where the spatial clusters were located for both the
years 2008 and 2012. In the analyses of univariate LISA, a lowto-low cluster indicated the county with a below-average
adherence rate that was also surrounded by the counties of
below-average adherence rates. If a low-to-low cluster was
identiﬁed in the same area in both years, it may imply a cluster of
counties with consistently low adherence. The patterns of
consistently low and high adherence to screening guidelines
were also presented in maps.
We also used GeoDa 1.8 software to map differential LISA
clusters[19,21] for mammography and CRC screening. Differential
LISA studies spatial autocorrelation on change over time. In this
study, the spatial patterns of county-level difference in adherence
from 2008 to 2012 were mapped by using differential LISA. The
county-level difference was calculated by subtracting the
adherence rate in 2008 from the rate in 2012. A positive value
of the difference indicates the possible increase in adherence from
2008 to 2012, a negative value means the possible decrease in
adherence, and a 0 value refers to no change. In addition, a highto-high cluster in differential LISA suggested a county with an

3. Results
3.1. Adherence to mammography screening guideline
A total of 2101 counties in 2008 and 2077 counties in 2012 were
included for analyzing mammography screening. Figure 1 shows
the maps of county-level adherence to mammography screening
3
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Figure 2. Results of local indicators for spatial analyses for mammography screening. A, Results of univariate local indicators for spatial analyses (LISA), which
illustrate the spatial patterns of adherence to mammography screening guidelines in 2008, are shown. B, Results of univariate LISA for adherence to mammography
screening guidelines in 2012 are shown. C, Maps the clusters that indicate consistently low or high adherence to mammography screening guidelines. D, Results of
differential LISA that depict the spatial autocorrelation on the change of adherence from 2008 to 2012.

3.2. Adherence to colorectal cancer screening guideline
A total of 1969 counties in 2008 and 2124 counties in 2012 were
included for the analysis of CRC screening (sigmoidoscopy/
colonoscopy/FOBT). The average county-level adherence to the
CRC screening guideline was 64.9% (SD 12.9%, range
30.4%–100%) in 2008 and 67.9% (SD 12.0%, range
29.7%–100%) in 2012, respectively. The mean ± SD for the
difference of county-level adherence rate from 2008 to 2012 was
3.1 ± 12.9% (range 47.9% to 58.37%). We mapped the rates of
adherence to the CRC screening guideline in 2008 and 2012 in
Fig. 3.
The Moran I of univariate LISA was 0.28 (P = 0.002) in 2008
and 0.29 (P = 0.002) in 2012, which indicated spatial clusters in
both years. Figure 4 (A–C) displays the spatial patterns by the
univariate LISA, and also areas identiﬁed as low-to-low cluster
and high-to-high cluster in both years. We found clusters of
consistently low adherence to the CRC screening guideline in
counties of New Mexico, Wyoming, Mississippi, and Louisiana
(P < 0.05), and also clusters of consistently high adherence in
Massachusetts (P < 0.05) from 2008 to 2012. The differential
Moran I was 2.6  10–5 (P = 0.49) for the adherence to the CRC
screening guideline, which also indicated a random spatial
pattern in the United States. Figure 4D presents the results of
differential LISA for CRC screening.
In addition, we have applied the sensitivity analyses using
both guidelines (ACS and USPSTF) for both county-level
cancer screening adherence. Most of the results remained the
same for the univariate LISA. We still found signiﬁcant low-tolow clusters in regard to the adherence to screening guidelines
over time in New Mexico, Wyoming, and Mississippi for the
adherence to both cancer screening guidelines. The low-to-low
clusters by the differential LISA in counties of Indiana for

guideline in years 2008 and 2012. The average county-level
adherence rates to mammography were 77.5% in 2008 (standard
deviation [SD] 10.9%, range 38.0%–100%) and 75.6% in 2012
(SD 11.2%, range 42.2%–100%), respectively. The mean ± SD
of the difference between the 2 years was 2.0 ± 12.4% (range
–47.4% to 42.3%).
Figure 2 (A–C) illustrates the results of univariate LISA for
county-level adherence to mammography. Moran I of the
univariate LISA in 2008 and 2012 were 0.17 (P = 0.002) and
0.22 (P = 0.002), respectively, suggesting potential spatial
clustering. We also identiﬁed and mapped areas of low-to-low
and high-to-high clusters in both years, which indicate
consistently low or high adherence to mammography screening
guideline. We consistently found low-to-low clusters in New
Mexico, Wyoming, Oklahoma, Mississippi, and northern
Indiana (P < 0.05), and high-to-high clusters in Massachusetts
(P < 0.05). We summarized the US states with the clusters of
consistently low and high adherence (Table 1), and clusters of
decreased and increased adherence to screening guidelines for
breast cancer and CRC (see Table 2, Supplemental Content that
presents counties identiﬁed as low-to-low clusters and high-tohigh cluster in the LISAs, http://links.lww.com/MD/B472).
Furthermore, differential Moran I was 0.002 (P = 0.42) for the
adherence to the mammography screening guideline, which
suggested a random spatial pattern of the United States. In the
differential LISA cluster map (Fig. 2D), we can see low-to-low
clusters in northern Indiana (P < 0.05), indicating a possible
decrease in adherence to mammography screening guideline from
2008 to 2012. On the contrary, a high-to-high cluster implying a
possible increase in adherence was identiﬁed in south Appalachia
(northern Alabama and Georgia), which was also conﬁrmed with
the exact values in those counties (data not provided).
4
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Table 1
Spatial patterns identiﬁed in the states of the US.
State
Alabama
Georgia
Indiana
Louisiana
Massachusetts
Mississippi
New Mexico
Oklahoma
Wyoming

Mammography screening

CRC screening

Clusters of increase in adherence
Clusters of increase in adherence
A cluster of consistently low adherence, clusters of decrease in adherence
—
Clusters of consistently high adherence
Clusters of consistently low adherence
Clusters of consistently low adherence
Clusters of consistently low adherence
A clusters of consistently low adherence

—
—
—
A cluster of consistently low adherence
A cluster of consistently high adherence
Clusters of consistently low adherence
Clusters of consistently low adherence
—
A cluster of consistently low adherence

Spatial clusters identiﬁed in other states not visually obvious were not listed in Table 1. CRC = colorectal cancer.

guidelines, using the updated data from a US nationally
representative sample. This study also demonstrated the
feasibility of using advanced spatial techniques such as the LISA
to identify spatial clusters of cancer screening guidelines adherence
across the US and examine how these spatial clusters may change
over time. Signiﬁcant geographical disparities across the United
States on the county-level adherence to mammogram and CRC
screening guidelines were found in both 2008 and 2012.
Consistently, low adherence to mammography screening
guideline was identiﬁed and clustered in areas of New Mexico,

mammography screening still existed; however, the high-tohigh clusters were not very obvious in southern Appalachia,
which were possibly effected by the inclusion criteria (women
over 75 years were not included in USPSTF guideline) (ﬁgures
not shown).

4. Discussion
The study is amongst the ﬁrst to explore spatial-temporal
variations in the adherence to breast cancer and CRC screening

Figure 3. County-level adherence to colorectal cancer screening guideline in 2008 and 2012, These maps show the county-level adherence to colorectal cancer
screening guideline in 2008 and 2012, using cut-off points at 50%, 60%, 70%, and 80%. Counties with missing values or excluded are ﬁlled with white color.
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Figure 4. Results of local indicators for spatial analyses for colorectal cancer screening. A, Results of univariate local indicators for spatial analyses (LISA), which
illustrate the spatial patterns of adherence to colorectal cancer (CRC) screening guidelines in 2008, are shown. B, Results of univariate LISA for adherence to CRC
screening guidelines in 2012 are shown. C Clusters of consistently low or high adherence to CRC screening guidelines in both years of 2008 and 2012 are shown.
D, Random spatial pattern in the United States on the change of adherence to CRC screening from 2008 to 2012, by using differential LISA, is shown.

lack of health insurance. At the US national level, the lack of
health insurance, area-level poverty rate, and out-of-pocket
expenditures were reported as signiﬁcant predictors of low
screening rate for CRC screenings.[25] Furthermore, although
primary care physicians play a critical role in implementing CRC
screening guidelines to their patients,[11] there were only 19.1%
of the primary care physicians in the United States adhering to the
screening recommendations.[28] In addition, there exist geographical variations in physicians’ nonadherence to the CRC
screening guideline. Yabroff et al found that primary care
physicians reported better guideline adherence on CRC screenings in the north central and the west regions of the United States
as compared with the southern region.[28] State variations in the
insurance coverage of CRC screenings may also impact the
participation rate. For example, coverage of CRC screening was
required in at least 29 states and the District of Columbia by
2010, which included New Mexico, Wyoming, Louisiana, but
not Mississippi.[29]
Several limitations in this study needs to be noted. First, we
were unable to cover all the counties in the United States, since we
used the data available in the BRFSS and only included data with
RSE <30%. Furthermore, using telephone surveys by the BRFSS
might lead to under-representation of racial/ethnic minorities,
women and younger individuals, with state variations in the
response rates, particularly in those states with lower response
rates.[30] This method also generally includes people with aboveaverage health awareness. Second, we used only 2 iterations of
the BRFSS in this study. More iterations may provide us with the
ability to capture more accurate temporal variations, which may
warrant future research to verify our ﬁndings. In addition, since
the BRFSS design is cross-sectional, the outcomes of independent
survey iterations might not be directly comparable. Still, the

Wyoming, Mississippi, Oklahoma, and Indiana. Northern
Indiana showed interesting results, in that not only was low
adherence to guidelines consistently found, but also clusters of
decrease in adherence to mammography screening were identiﬁed. However, there seems to be a lack of research on the
geographic disparity and potential targeted interventions to
improve mammography screening in this region. However,
clusters of an increase in adherence in southern Appalachia
including northern Alabama and Georgia were observed. This
may possibly be attributed to the continuous efforts to improve
mammography screening in this region. For example, the
Alabama Breast and Cervical Cancer Early Detection Program[22]
offers free breast and cervical cancer screenings, which include
mammograms for women who meet the eligibility guidelines (eg,
income 200% of the federal poverty guidelines, without
insurance or underinsured). There are also other interventions
and initiatives occurring in the Appalachian region to improve
breast cancer screenings, for example, mobile mammography
screening programs.[23,24,21] In West Virginia, for instance,
“Bonnie Bus,” a mobile mammography unit, travels across West
Virginia and offers breast cancer screenings to women who
qualify for the program since 2009.[24] These programs may serve
as good examples for the health underserved areas identiﬁed in
our study.
In terms of CRC screening, consistently low adherence to the
CRC screening guideline was identiﬁed in New Mexico,
Wyoming, Louisiana, and Mississippi. The ﬁnding in the
southeast parts of New Mexico was consistent with previous
studies.[25–27] These studies found that low CRC screening rate in
New Mexico may be associated with transformative and/or
stigmatizing embarrassment, fear of pain and discomfort, low
CRC knowledge, insufﬁcient patient–physician discussion, and
6
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BRFSS data are representative of the total noninstitutionalized
population over 18 years of age, given that it uses stratiﬁed
random sampling design in each state of the United States among
over 0.4 million adults every year. Third, we were not able to
exclude those patients who had already been diagnosed with
breast cancer or CRC from the analyses. Fourth, we did not
include all CRC screening tests due to the limited available data.
The recommendations used in this study may not be applied to
individuals with positive BRCA gene test, family history of breast
cancer, inﬂammatory bowel disease, and prior history of colon
polyps; however, we cannot differentiate participants with these
conditions in this analysis by using the BRFSS data. Finally, we
used up-to-date guidelines by the ACS and USPSTF in this study,
but variations on adherence rate could be expected if other
guidelines or versions were utilized. The recommendations from
the ACS mammography screening guideline 2015 version were
less strict than those from previous versions, so we expect
mammography screening adherence rate would be lower if we
had applied previous versions (eg, 2008 version). Nevertheless,
given our focus on the spatial-temporal variations, we need to
choose 1 guideline for each cancer screening to facilitate
comparisons over time.

5. Conclusion
We found low-to-low clusters over time in adherence to screening
guidelines for both cancer types in New Mexico, Wyoming, and
Mississippi, and clusters of potential decrease in adherence to
mammography screening guideline in counties of Indiana. Our
study ﬁndings also showed improvement on mammography
screening in southern Appalachia. Overall, further research,
targeted intervention, or policy may be warranted in the areas
with clusters of consistently low adherence to screening and
decrease in adherence. Reducing structural barriers, providing
one-to-one education, increasing provider assessment and
feedback, and reducing out-of-pocket costs may be effective
strategies to improve breast cancer and/or CRC screening.[31,32]

References
[1] National Cancer Institute. Common Cancer Types: updated 2016.
Available at: http://www.cancer.gov/types/common-cancers. Accessed
October 20, 2016.
[2] American Cancer society. Cancer facts and Figures 2016: updated 2016.
Available at: http://www.cancer.org/acs/groups/content/@research/docu
ments/document/acspc-047079.pdf. Accessed October 21, 2016.
[3] National Cancer Institute 1/12/2011. Cancer costs projected to reach at
least $158 billion in 2020; updated 2011. Available at https://www.
cancer.gov/news-events/press-releases/2011/CostCancer2020. Accessed
by October 21, 2016
[4] Tabar L, Yen M, Vitak B, et al. Mammography service screening and
mortality in breast cancer patients: 20-year follow-up before and after
introduction of screening. Lancet 2003;361:1405–10.
[5] Gøtzsche PC, Jørgensen KJ. Screening for Breast Cancer With
Mammography. The Cochrane Library 2013.
[6] American Cancer Society. History of ACS recommendations for the early
detection of cancer in people without symptoms: updated 2015.
Available at: http://www.cancer.org/healthy/ﬁndcancerearly/cancerscree
ningguidelines/chronological-history-of-acs-recommendations. Accessed
May 30, 2016.
[7] National Cancer Institute. Screening Rates for Several Cancers Miss
Their Targets. https://www.cancer.gov/news-events/cancer-currentsblog/2015/screening-targets. Accessed October 20, 2016.
[8] Henry KA, McDonald K, Sherman R, et al. Association between
individual and geographic factors and nonadherence to mammography
screening guidelines. J Women Health 2014;23:664–74.

7

